SPI Healthcare
3.592,83
PKT
+39,03
PKT
+1,10
%
Werbung
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 09.12.22 | Novartis Sell | Deutsche Bank AG | |
| 08.12.22 | Novartis Market-Perform | Bernstein Research | |
| 08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.12.22 | Novartis Sell | Deutsche Bank AG | |
| 06.12.22 | Novartis Neutral | UBS AG | |
| 02.12.22 | Roche Hold | Deutsche Bank AG | |
| 22.11.22 | Novartis Sell | Deutsche Bank AG | |
| 15.11.22 | Roche Hold | Deutsche Bank AG | |
| 14.11.22 | Roche Outperform | Credit Suisse Group | |
| 14.11.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | Roche Overweight | Barclays Capital | |
| 14.11.22 | Roche Buy | Jefferies & Company Inc. | |
| 14.11.22 | Roche Neutral | UBS AG | |
| 14.11.22 | Roche Outperform | Bernstein Research | |
| 01.11.22 | Roche Hold | Deutsche Bank AG | |
| 27.10.22 | Novartis Sell | Deutsche Bank AG | |
| 26.10.22 | Novartis Market-Perform | Bernstein Research | |
| 26.10.22 | Novartis Underperform | Credit Suisse Group | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.10.22 | Novartis Underweight | Barclays Capital | |
| 25.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.10.22 | Novartis Sell | Deutsche Bank AG | |
| 25.10.22 | Novartis Neutral | UBS AG | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 24.10.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.10.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.10.22 | Roche Hold | Deutsche Bank AG | |
| 19.10.22 | Roche Outperform | Credit Suisse Group | |
| 19.10.22 | Roche Overweight | Barclays Capital | |
| 18.10.22 | Roche Neutral | UBS AG | |
| 18.10.22 | Roche Buy | Jefferies & Company Inc. | |
| 18.10.22 | Roche Outperform | Bernstein Research | |
| 18.10.22 | Roche Overweight | Barclays Capital | |
| 18.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.10.22 | Roche Outperform | Credit Suisse Group | |
| 14.10.22 | Novartis Underweight | Barclays Capital |